skip to Main Content

Macrophage-Expressed CD51 Promotes Cancer Stem Cell Properties Via the TGF-β1/smad2/3 Axis in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Macrophage-targeted therapy offers new options for intractable pancreatic ductal adenocarcinoma (PDAC), which has a low 5-year survival rate. However, the factors regulating the biological function and phenotype of macrophages in PDAC are incompletely understood.

Read more . . . 

Back To Top